Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
Morgan RJ Jr, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH.
Morgan RJ Jr, et al. Among authors: najera l.
Gynecol Oncol. 1999 Dec;75(3):419-26. doi: 10.1006/gyno.1999.5613.
Gynecol Oncol. 1999.
PMID: 10600300
Clinical Trial.